Luk H. Vandenberghe
Affiliations: | Harvard Medical School, Boston, MA, United States |
Area:
AAV, Vector development, Ocular Gene Transfer, Vaccines, Immunology, Retinal degenerationsGoogle:
"Luk Vandenberghe"Cross-listing: GenetiTree - Cell Biology Tree
Parents
Sign in to add mentor| Jean Bennett | grad student | Penn | |
| Zeger Debyser | grad student | KU Leuven | |
| Carl H. June | grad student | Penn | |
| James M. Wilson | grad student | Penn |
Children
Sign in to add trainee| Livia Carvalho | post-doc | 2013-2015 | University of Perth, Australia |
| Nerea Zabaleta | post-doc | 2019-2022 | Harvard Medical School - Massachusetts Eye and Ear |
| Eric Zinn | research scientist | 2012-2015 | Harvard Medical School |
Collaborators
Sign in to add collaborator| Sadik H Kassim | collaborator | ||
| Casey A. Maguire | collaborator | The Massachusetts General Hospital |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kumar P, Wang M, Kumru OS, et al. (2023) Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate. Molecular Therapy. Methods & Clinical Development. 30: 103-121 |
| Reichart D, Newby GA, Wakimoto H, et al. (2023) Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nature Medicine |
| Hsu Y, Bhattarai S, Thompson JM, et al. (2022) Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model. Molecular Therapy. Nucleic Acids. 31: 164-181 |
| Florea M, Nicolaou F, Pacouret S, et al. (2022) High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography. Molecular Therapy. Methods & Clinical Development. 28: 146-159 |
| Zinn E, Unzu C, Schmit PF, et al. (2022) Ancestral library identifies conserved reprogrammable liver motif on AAV capsid. Cell Reports. Medicine. 100803 |
| Lu YC, Tsai YH, Chan YH, et al. (2022) Gene therapy with a synthetic adeno-associated viral vector improves audiovestibular phenotypes in Pjvk-mutant mice. Jci Insight. 7 |
| Zabaleta N, Bhatt U, Hérate C, et al. (2022) Durable immunogenicity, adaptation to emerging variants and low dose efficacy of AAV-based COVID19 platform in macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Maciorowski D, Diop C, Bhatt U, et al. (2022) Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging. Viruses. 14 |
| Naninck T, Kahlaoui N, Lemaitre J, et al. (2022) Computed tomography and [F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates. Iscience. 25: 104101 |
| Andres-Mateos E, Landegger LD, Unzu C, et al. (2022) Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate. Nature Communications. 13: 1359 |